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General Information
Virology
Noroviruses (genus Norovirus, family Caliciviridae) are a 
group of related, single-stranded RNA, non-enveloped 
viruses that cause acute gastroenteritis in humans.
Norovirus is the official genus name for the group of viruses 
provisionally described as "Norwalk-like viruses". Currently, 
human noroviruses belong to one of three norovirus 
genogroups (GI, GII, or GIV), which are further divided 
into >25 genetic clusters. Over 75% of confirmed human 
norovirus infections are associated with genotype GII.
Clinical manifestations
The average incubation period for norovirus-associated 
gastroenteritis is 12 to 48 hours, with a median period 
of approximately 33 hours. Illness is characterized by 
nausea, acute-onset vomiting, and watery, non-bloody 
diarrhea with abdominal cramps. In addition, myalgia, 
malaise, and headache are commonly reported. Low- 
grade fever is present in about half of cases. Dehydration 
is the most common complication and may require 
intravenous replacement fluids. Symptoms usually 
last 24 to 60 hours. Up to 30% of infections may be 
asymptomatic.
Epidemiology o f transmission 
Noroviruses are highly contagious, with as few as 18 
virus particles thought to be sufficient to cause infection. 
This pathogen is estimated to be the causative agent 
in over 21 million gastroenteritis cases every year in 
the United States, representing approximately 60% of 
all acute gastroenteritis cases from known pathogens. 
Noroviruses are transmitted primarily through the fecal- 
oral route, either by direct person-to-person spread or 
fecally contaminated food or water. Noroviruses can 
also spread via a droplet route from vomitus. These 
viruses are relatively stable in the environment and 
can survive freezing and heating to 60°C (140°F). In 
healthcare facilities, transmission can also occur through
hand transfer of the virus to the oral mucosa via contact with 
materials, fomites, and environmental surfaces that have been 
contaminated with either feces or vomitus.
Norovirus infections are seen in all age groups, although severe 
outcomes and longer durations of illness are most likely to 
be reported among the elderly. Among hospitalized persons 
who are immunocompromised or have significant medical 
comorbidities, norovirus infection can directly result in prolonged 
hospital stays, additional medical complications, and, rarely, 
death. There is currently no vaccine available for norovirus and, 
generally, no specific medical treatment is offered for norovirus 
infection apart from oral or intravenous repletion of volume.
The ease of its transmission, a very low infectious dose, a short 
incubation period, environmental persistence, and lack of durable 
immunity following infection enables norovirus to spread rapidly 
through confined populations. Healthcare facilities and other 
institutional settings (e.g., daycare centers, schools, etc.) are 
particularly at-risk for outbreaks because of increased person- 
to-person contact. Healthcare facilities managing outbreaks of 
norovirus gastroenteritis may experience significant costs relating 
to isolation precautions and personal protective equipment, ward 
closures, supplemental environmental cleaning, staff cohorting or 
replacement, and sick time.
Diagnosis o f  norovirus infection 
Diagnosis of norovirus infection relies on the detection of 
viral RNA in the stools of affected persons, by use of reverse 
transcription-polymerase chain reaction (RT-PCR) assays. This 
technology is available at CDC and most state public health 
laboratories and should be considered in the event of outbreaks 
of gastroenteritis in healthcare facilities. Enzyme immune-assays 
may also be used for identification of norovirus outbreak but are 
not recommended for diagnosis of individuals. Identification of 
the virus can be best made from stool specimens taken within 48 
to 72 hours after onset of symptoms, although positive results can 
be obtained by using RT-PCR on samples taken as long as 7 days 
after symptom onset. Because of the limited availability of timely 
and routine laboratory diagnostic methods, a clinical diagnosis of 
norovirus infection is often used, especially when other agents of 
gastroentertis have been ruled out.
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Measures to Limit Transmission*
Patient Cohorting and Isolation Precautions 
Avoid exposure to vomitus or diarrhea. Place patients on 
Contact Precautions in a single occupancy room if they present 
with symptoms consistent with norovirus gastroenteritis
Hand Hygiene
During outbreaks, use soap and water for hand hygiene after 
providing care or having contact with patients suspected or 
confirmed with norovirus gastroenteritis.
Patient Transfer and Ward Closure 
Consider limiting transfers to those for which the receiving 
facility is able to maintain Contact Precautions; otherwise, it 
may be prudent to postpone transfers until patients no longer 
require Contact Precautions. During outbreaks, medically 
suitable individuals recovering from norovirus gastroenteritis 
can be discharged to their place of residence.
S taff Leave and Policy
Develop and adhere to sick leave policies for healthcare personnel 
who have symptoms consistent with norovirus infection.
Exclude ill personnel from work for a minimum of 48 hours after 
the resolution of symptoms. Once personnel return to work, the 
importance of performing frequent hand hygiene should be 
reinforced, especially before and after each patient contact.
Establish protocols for staff cohorting in the event of an outbreak 
of norovirus gastroenteritis. Ensure staff care for one patient 
cohort on their ward and do not move between patient cohorts 
(e.g., patient cohorts may include symptomatic, asymptomatic 
exposed, or asymptomatic unexposed patient groups).
Diagnostics
In the absence of clinical laboratory diagnostics or in the case 
of delay in obtaining laboratory results, use Kaplan's clinical and 
epidemiologic criteria to identify a norovirus gastroenteritis 
outbreak.
Kaplan's Criteria
1. Vomiting in more than half of symptomatic cases and,
2. Mean (or median) incubation period of 24 to 48 hours and,
3. Mean (or median) duration of illness of 12 to 60 hours and,
4. No bacterial pathogen isolated in stool culture
Environmental Cleaning
Increase the frequency of cleaning and disinfection of 
patient care areas and frequently touched surfaces during 
outbreaks of norovirus gastroenteritis (e.g., increase ward/ 
unit level cleaning to twice daily to maintain cleanliness, 
with frequently touched surfaces cleaned and disinfected 
three times daily using the US Environmental Protection 
Agency's list of approved products for healthcare settings 
(http://www.epa.gov/oppad001/chemregindex.htm).
CS216887-ANorovirusFactSheet
Communication and Notification  
As with all outbreaks, notify appropriate local and state health 
departments, as required by state and local public health 
regulations, if an outbreak of norovirus gastroenteritis is 
suspected.
^Prevention and control recommendations taken from priority 
recommendations in the CDC HICPAC Guideline for the Prevention 
and Control of Norovirus Gastroenteritis Outbreaks in Healthcare 
Settings (http://www.cdc.gov/hicpac/pdf/norovirus/Norovirus- 
Guideline-2011.pdf)
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